Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Epigenetics|October 1, 2016
CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patientsSebastian Meller, Lisa Zipfel, Heidrun Gevensleben, et al.
The Journal of Molecular Diagnostics : JMD|December 13, 2016
PITX2 DNA Methylation as Biomarker for Individualized Risk Assessment of Prostate Cancer in Core BiopsiesBarbara Uhl, Heidrun Gevensleben, Yuri Tolkach, et al.
Acta Neuropathologica|October 3, 2006
Activation of Akt independent of PTEN and CTMP tumor-suppressor gene mutations in epilepsy-associated Taylor-type focal cortical dysplasiasVolker Schick, Michael Majores, Gudrun Engels, et al.
Neurosurgery|December 15, 2010
Presence of temporal gray-white matter abnormalities does not influence epilepsy surgery outcome in temporal lobe epilepsy with hippocampal sclerosisOlaf E M G Schijns, Christian G Bien, Michael Majores, et al.
Journal of Cancer Research and Clinical Oncology|February 4, 2024
Expression of the microtubule-associated protein 2 (MAP2) as a potential independent prognostic marker in prostate cancerJohannes Stein, Eliana Krappe, Anika Kremer, et al.
The American Journal of Pathology|July 13, 2014
KDM5C is overexpressed in prostate cancer and is a prognostic marker for prostate-specific antigen-relapse following radical prostatectomyJohannes Stein, Michael Majores, Magdalena Rohde, et al.
Journal of Neuropathology and Experimental Neurology|July 27, 2005
Distinct allelic variants of TSC1 and TSC2 in epilepsy-associated cortical malformations without balloon cellsMichael Majores, Ingmar Blümcke, Horst Urbach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2015
The Immune Checkpoint Regulator PD-L1 Is Highly Expressed in Aggressive Primary Prostate CancerHeidrun Gevensleben, Dimo Dietrich, Carsten Golletz, et al.
Oncotarget|April 7, 2016
Comprehensive analysis of the transcriptional profile of the Mediator complex across human cancer typesIsabella Syring, Niklas Klümper, Anne Offermann, et al.
Pageof 3